These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 3104751)

  • 1. Intrathecal thyrotropin-releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D
    Neurol Clin; 1987 Feb; 5(1):159-70. PubMed ID: 3104751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic trial of intrathecal thyrotropin-releasing hormone (TRH) and a TRH-analogue in amyotrophic lateral sclerosis (ALS).
    Thielen T; Stober T; Schimrigk K
    Adv Exp Med Biol; 1987; 209():305-8. PubMed ID: 3107352
    [No Abstract]   [Full Text] [Related]  

  • 3. [Treatment of amyotrophic lateral sclerosis with thyrotropin releasing hormone].
    Serratrice G; Desnuelle C; Crevat A; Guelton C; Meyer-Dutour A
    Rev Neurol (Paris); 1986; 142(2):133-9. PubMed ID: 3088700
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Treatment of amyotrophic lateral sclerosis with daily intrathecal TRH. A year's experience. Pilot study II].
    Patrignani J; Proaño J; Morales MD
    Neurologia; 1992 Jan; 7(1):4-9. PubMed ID: 1596403
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prolonged intrathecal infusion of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Munsat TL; Taft J; Kasdon D; Jackson IM
    Ann N Y Acad Sci; 1988; 531():187-93. PubMed ID: 3132882
    [No Abstract]   [Full Text] [Related]  

  • 6. [Trials of 1-cysteine, TRH and 5HTP in amyotrophic lateral sclerosis].
    Akiguchi I; Kato T; Sugiyama H
    Rinsho Shinkeigaku; 1984 Dec; 24(12):1270-3. PubMed ID: 6442975
    [No Abstract]   [Full Text] [Related]  

  • 7. Intravenous thyrotropin-releasing hormone in patients with amyotrophic lateral sclerosis. Dose-response and randomized concurrent placebo-controlled pilot studies.
    Brooks BR; Sufit RL; Montgomery GK; Beaulieu DA; Erickson LM
    Neurol Clin; 1987 Feb; 5(1):143-58. PubMed ID: 3104750
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical, electrophysiologic and endocrine effects of the perfusion of high doses of TRH in amyotrophic lateral sclerosis].
    Gueguen B; Puymirat J; Grouselle D; Piketty ML; Bleton JP; Bourdel MC; Rondot P
    Rev Neurol (Paris); 1988; 144(11):704-9. PubMed ID: 3148186
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Intrathecal thyrotropin-releasing hormone does not alter the progressive course of ALS: experience with an intrathecal drug delivery system.
    Munsat TL; Taft J; Jackson IM; Andres PL; Hollander D; Skerry L; Ordman M; Kasdon D; Finison L
    Neurology; 1992 May; 42(5):1049-53. PubMed ID: 1579228
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intrathecal thyrotropin-releasing hormone therapy of amyotrophic lateral sclerosis.
    Stober T; Schimrigk K; Dietzsch S; Thielen T
    J Neurol; 1985; 232(1):13-4. PubMed ID: 3923160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Note on the use of TRH in amyotrophic lateral sclerosis].
    Serratrice G
    Bull Acad Natl Med; 1985 Oct; 169(7):1013-7. PubMed ID: 3938669
    [No Abstract]   [Full Text] [Related]  

  • 12. Current status of thyrotropin-releasing hormone therapy in amyotrophic lateral sclerosis. Committee on Health Care Issues, American Neurological Association.
    Ann Neurol; 1987 Oct; 22(4):541-3. PubMed ID: 3124710
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacokinetics of intrathecal thyrotropin-releasing hormone.
    Munsat TL; Taft J; Jackson IM
    Neurology; 1987 Apr; 37(4):597-601. PubMed ID: 3104819
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Preliminary clinical study on the treatment of amyotrophic lateral sclerosis with TRH].
    Formisano R; Antonini G; Bove R; Millefiorini M; Ruggieri S
    Clin Ter; 1986 Dec; 119(6):479-81. PubMed ID: 3102155
    [No Abstract]   [Full Text] [Related]  

  • 15. [Spinal mechanism of the antispastic action of TRH in patients with amyotrophic lateral sclerosis].
    Morin C; Pierrot-Deseilligny E
    Rev Neurol (Paris); 1988; 144(11):701-3. PubMed ID: 3148185
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect on weakness and spasticity in amyotrophic lateral sclerosis of thyrotropin-releasing hormone.
    Engel WK; Siddique T; Nicoloff JT
    Lancet; 1983 Jul; 2(8341):73-5. PubMed ID: 6134961
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Controlled trial of thyrotropin releasing hormone in amyotrophic lateral sclerosis.
    Brooke MH; Florence JM; Heller SL; Kaiser KK; Phillips D; Gruber A; Babcock D; Miller JP
    Neurology; 1986 Feb; 36(2):146-51. PubMed ID: 3080694
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of motor neuron diseases using intrathecal TRH. Pilot study I].
    Patrignani Ochoa J; Morales Martínez D; Martínez Parra C
    Neurologia; 1988; 3(6):221-5. PubMed ID: 3152558
    [No Abstract]   [Full Text] [Related]  

  • 19. A double-blind, placebo-controlled trial of TRH in amyotrophic lateral sclerosis.
    Caroscio JT; Cohen JA; Zawodniak J; Takai V; Shapiro A; Blaustein S; Mulvihill MN; Loucas SP; Gudesblatt M; Rube D
    Neurology; 1986 Feb; 36(2):141-5. PubMed ID: 3080693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Thyrotropin releasing hormone uptake into serum and cerebrospinal fluid following intravenous or subcutaneous administration.
    Brooks BR; Kalin N; Beaulieu DA; Barksdale C; Sufit RL; Dills DG
    Neurol Res; 1988 Dec; 10(4):236-8. PubMed ID: 2907112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.